Skip to main content
logo
Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
4.250
+0.040 (0.95%)
At close: Jun 26, 2026, 4:00 PM EDT
4.240
-0.010 (-0.24%)
After-hours: Jun 26, 2026, 7:57 PM EDT

Revenue by Segment

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Innovating, Developing & Commercializing Therapies Using Autologous TIL
263.50M164.07M1.19M--
Innovating, Developing & Commercializing Therapies Using Autologous TIL Growth
60.60%13698.99%---
Total
263.50M164.07M1.19M--
Total Growth
60.60%13698.99%---

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
United States
259.01M161.04M---
United States Growth
60.83%----
Rest of World
4.49M3.03M1.19M--
Rest of World Growth
48.30%154.58%---
Total
263.50M164.07M1.19M--
Total Growth
60.60%13698.99%---